RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Fixed Drug Eruption Due to Allopurinol: Positive Oral Provocation

      한글로보기

      https://www.riss.kr/link?id=A103914028

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      A fixed drug eruption (FDE) is characterized by the presence of a solitary or multiple, pruritic, well-circumscribed, erythematous plaques. These lesions have tendency to recur at same sites and heal with residual hyperpigmenation. With repeated attac...

      A fixed drug eruption (FDE) is characterized by the presence of a solitary or multiple, pruritic, well-circumscribed, erythematous plaques. These lesions have tendency to recur at same sites and heal with residual hyperpigmenation. With repeated attacks, the size and/or number of the lesions may increase. So far, more than 100 drugs have been implicated in causing FDEs, including ibuprofen, sulfonamide, naproxen,and tetracylines. FDE caused by allopurinol has been rarely reported in the literature, but there has been no confirmed case based on oral provocation test. Herein, we report a case of FDE in which the lesions recurred whenever allopurinol was administered for the treatment of gout. A 64-year-old male experienced repeated episodes of welldemarcated dusky erythematous patches on the whole body for 2 months. He took allopurinol intermittently for amelioration of his gout symptom, but denied other medication history. Pruritic erythematous edema developed on the previous lesions 12 hours after oral provocation of 200 mg of allopurinol. (Ann Dermatol 23(S3) S402∼S403, 2011)

      더보기

      참고문헌 (Reference)

      1 Lee AY, "Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years" 38 : 258-260, 1998

      2 Zedlitz S, "Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing" 46 : 352-353, 2002

      3 Lee AY, "Fixed drug eruptions. Incidence, recognition, and avoidance" 1 : 277-285, 2000

      4 Shiohara T, "Fixed drug eruption: pathogenesis and diagnostic tests" 9 : 316-321, 2009

      5 Tsai TF, "Allopurinol in dermatology" 11 : 225-232, 2010

      1 Lee AY, "Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years" 38 : 258-260, 1998

      2 Zedlitz S, "Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing" 46 : 352-353, 2002

      3 Lee AY, "Fixed drug eruptions. Incidence, recognition, and avoidance" 1 : 277-285, 2000

      4 Shiohara T, "Fixed drug eruption: pathogenesis and diagnostic tests" 9 : 316-321, 2009

      5 Tsai TF, "Allopurinol in dermatology" 11 : 225-232, 2010

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2009-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2007-01-01 평가 SCOPUS 등재 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.11 0.23 0.72
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.67 0.48 0.376 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼